Surmodics Inc (FRA:SU6)
€ 33.8 0 (0%) Market Cap: 494.12 Mil Enterprise Value: 489.78 Mil PE Ratio: 0 PB Ratio: 4.54 GF Score: 82/100

Q3 2021 Surmodics Inc Earnings Call Transcript

Aug 04, 2021 / 12:30PM GMT
Release Date Price: €47.2 (+2.61%)
Operator

Good day, everyone, and thank you for standing by. Welcome to the Surmodics Third Quarter Fiscal 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Tim Arens, Senior Vice President of Finance and Chief Financial Officer. Please go ahead, sir.

Timothy J. Arens
Surmodics, Inc. - Senior VP of Finance & Information Technology and CFO

Thank you, Hannah. Good morning, and welcome to Surmodics' fiscal 2021 third quarter earnings call. Before we begin, I would like to remind you that during this call, we will make forward-looking statements. These forward-looking statements are covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements regarding Surmodics' future financial and operating results or other statements that are not historical facts. Please be advised that actual results could differ materially from those stated or implied by our forward-looking statements resulting from certain risks and uncertainties, including those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot